Status:
COMPLETED
AVACEN Treatment Method and Postprandial Blood Glucose
Lead Sponsor:
San Diego State University
Conditions:
Postprandial Hyperglycemia
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on postprandial blood glucose. The AVACEN device creates negative pressure around the hand while he...
Eligibility Criteria
Inclusion
- Healthy individuals
Exclusion
- Diagnosis of diabetes, diabetes medication, hypertension medication
Key Trial Info
Start Date :
May 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2019
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04018976
Start Date
May 5 2019
End Date
September 15 2019
Last Update
October 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jeff Moore
San Diego, California, United States, 92182